{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:23:33Z","timestamp":1762507413209},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T00:00:00Z","timestamp":1526256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00399-018-0559-x","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T13:07:12Z","timestamp":1526303232000},"page":"228-232","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reise des S\u2011ICD zur First-Line-Therapie"],"prefix":"10.1007","volume":"29","author":[{"given":"Elif","family":"Kaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Wakili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tienush","family":"Rassaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,14]]},"reference":[{"issue":"7","key":"559_CR1","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","volume":"15;102","author":"KH Kuck","year":"2000","unstructured":"Kuck KH, Cappato R, Siebels J, R\u00fcppel R (2000) Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 15;102(7):748\u2013754","journal-title":"Circulation"},{"issue":"6","key":"559_CR2","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.hrthm.2008.04.015","volume":"5","author":"AE Epstein","year":"2008","unstructured":"Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA, Freedman RA, Gettes LS et al (2008) ACC\/AHA\/HRS 2008\u00a0guidelines\u00a0for\u00a0Device-Based\u00a0Therapy\u00a0of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm 5(6):934\u2013955. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2008.04.015","journal-title":"Heart Rhythm"},{"issue":"12","key":"559_CR3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa013474","volume":"346","author":"AJ Moss","year":"2002","unstructured":"Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et\u00a0al (2002) Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a\u00a0defibrillator in patients with myocardial infarction and reduced ejection fraction. N\u00a0Engl J Med 346(12):877\u2013883","journal-title":"N Engl J Med"},{"issue":"19","key":"559_CR4","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.663807","volume":"115","author":"T Kleemann","year":"2007","unstructured":"Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S et al (2007) Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a\u00a0period of \u300910 years. Circulation 115(19):2474\u20132480","journal-title":"Circulation"},{"issue":"8","key":"559_CR5","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.hrthm.2013.05.016","volume":"10","author":"RE Knops","year":"2013","unstructured":"Knops RE, Nordkamp OLR, de Groot JR, Wilde AA (2013) Two-incision\u00a0technique\u00a0for implantation of the subcutaneous implantable cardioverter-defibrillator. Heart Rhythm 10(8):1240\u20131243. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2013.05.016","journal-title":"Heart Rhythm"},{"issue":"9","key":"559_CR6","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","volume":"128","author":"R Weiss","year":"2013","unstructured":"Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M et\u00a0al (2013) Safety and efficacy of a\u00a0totally subcutaneous implantable cardioverter defibrillator. Circulation 128(9):944\u2013953. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.003042","journal-title":"Circulation"},{"issue":"25","key":"559_CR7","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1093\/eurheartj\/ehu112","volume":"35","author":"PD Lambiase","year":"2014","unstructured":"Lambiase PD, Barr C, Theuns DA, Knops R, Neuzil P, Johansen JB et al (2014) Worldwide experience with a\u00a0totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S\u2011ICD Registry. Eur Heart\u00a0J 35(25):1657\u20131665. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehu112","journal-title":"Eur Heart J"},{"issue":"7","key":"559_CR8","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.jacc.2017.06.040","volume":"70","author":"L Boersma","year":"2017","unstructured":"Boersma L, Barr C, Knops R, Theuns D, Eckardt L, Neuzil P et al (2017) Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study. J\u00a0Am Coll Cardiol 70(7):830\u2013841. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2017.06.040","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"559_CR9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.recesp.2016.01.001","volume":"69","author":"SG Priori","year":"2016","unstructured":"Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J et al (2016) 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Rev Esp Cardiol 69(2):176. \n                    https:\/\/doi.org\/10.1016\/j.rec.2016.01.001","journal-title":"Rev Esp Cardiol"},{"key":"559_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2017.10.035","author":"SM Al-Khatib","year":"2017","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, Gillis AM, Bryant WJ, Hlatky MA et al (2017) 2017\u00a0AHA\/ACC\/HRS\u00a0guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the heart rhythm society. Heart Rhythm. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2017.10.035","journal-title":"Heart Rhythm"},{"key":"559_CR11","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1001\/jamacardio.2016.2782","volume":"1","author":"DJ Friedman","year":"2016","unstructured":"Friedman DJ, Parzynski CS, Varosy PD, Prutkin JM, Patton KK et\u00a0al (2016) Trends and In-hospital Outcomes Associated With Adoption of the Subcutaneous Implantable Cardioverter Defibrillator in the United Sates. JAMA Cardiol 1:900\u2013911. \n                    https:\/\/doi.org\/10.1001\/jamacardio.2016.2782","journal-title":"Jama Cardiol"},{"key":"559_CR12","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.jacc.2016.08.044","volume":"68","author":"TF Brouwer","year":"2016","unstructured":"Brouwer TF, Yilmaz D, Lindeboom R, Buiten MS, Nordkamp OLR, Schalij MJ et al (2016) Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy. J Am Coll Cardiol 68:2047\u20132055","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"559_CR13","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1161\/CIRCEP.113.000481","volume":"6","author":"JE Poole","year":"2013","unstructured":"Poole JE, Gold MR (2013) Who\u00a0should\u00a0receive\u00a0the\u00a0subcutaneous\u00a0implanted\u00a0defibrillator?: The\u00a0subcutaneous implantable cardioverter defibrillator\u00a0(ICD) should be\u00a0considered\u00a0in all\u00a0ICD patients\u00a0who\u00a0do not require pacing. Circ Arrhythm Electrophysiol 6(6):1236\u20131244. \n                    https:\/\/doi.org\/10.1161\/CIRCEP.113.000481\n                    \n                   (discussion 1244\u20135)","journal-title":"Circ Arrhythm Electrophysiol"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00399-018-0559-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-018-0559-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-018-0559-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T04:43:16Z","timestamp":1557808996000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00399-018-0559-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,14]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["559"],"URL":"https:\/\/doi.org\/10.1007\/s00399-018-0559-x","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,14]]},"assertion":[{"value":"27 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"R.\u00a0Wakili erhielt Honorare f\u00fcr Beratert\u00e4tigkeit, Vortragt\u00e4tigkeit und f\u00fcr von ihm initiierte Forschungsvorhaben von der Firma Boston Scientific. E.\u00a0Kaya und T.\u00a0Rassaf geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}